Shareholder information

Head Office

Ambrilia Biopharma Inc.
1010 Sherbrooke Street West, Suite 1800
Montreal, Quebec, H3A 2R7
Tel.: (514) 751-2003
Fax: (514) 751-2502
www.ambrilia.com

Stock Listing

Listing: Toronto Stock Exchange (TSX)
Symbol: AMB

Transfer Agent and Registrar

Computershare Investor Services
1500 University Street, 7th Floor
Montreal, Quebec H3A 3S8
Tel.: (514) 982-7888

Auditors

Ernst & Young LLP

Corporate Counsel

Fasken Martineau DuMoulin LLP

Annual and Special Meeting of Shareholders

The Annual and Special Meeting of Shareholders of Ambrilia will be held within a 3 month period following emergence of the company from protection under CCAA. The location of this meeting will be determined and announced at a later date.

Investor Information and Inquiries

Contact: Richard La Rue
Interim President & CEO
Tel.: (514) 751-2003 ex. 269
e-mail: rlarue@ambrilia.com

All filings for Ambrilia Biopharma Inc. are available through SEDAR.

 

Stock quote

Symbol TSX : AMB
Last trade 0.025
Volume 750
As of 2010-03-08
15:44 EST
Note: Quotes are delayed.
For informational purposes only.

Financial Reports